vTv Therapeutics Inc. Profile Avatar - Palmy Investing

vTv Therapeutics Inc.

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activa…

Biotechnology
US, High Point [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

vTv Therapeutics Inc. has no acquisition track records yet.

M&A Deals · History

vTv Therapeutics Inc. has no acquisition track records yet.

End of VTVT's Analysis
CIK: 1641489 CUSIP: 918385105 ISIN: US9183852048 LEI: - UEI: -
Secondary Listings
VTVT has no secondary listings inside our databases.